Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperphosphatemia Patients on Hemodialysis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT06406140
What this trial is testing

Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis Patients

Who this might be right for
End-stage Renal Disease
Al-Azhar University 50
Early research (Phase 1)Study completedNCT00316472
What this trial is testing

The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients

Who this might be right for
Hyperphosphatemia
Washington University School of Medicine 40
Testing effectiveness (Phase 2)Study completedNCT00853242
What this trial is testing

Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis

Who this might be right for
Kidney Failure, Chronic
Genzyme, a Sanofi Company 349
Not applicableUnknownNCT03236701
What this trial is testing

Egg White for Phosphorus Control in Haemodialysis Patients

Who this might be right for
Renal Insufficiency, ChronicDialysisHyperphosphatemia
Federico II University 20
Large-scale testing (Phase 3)Study completedNCT06745531
What this trial is testing

TS-172 in Hyperphosphatemia Patients on Hemodialysis

Who this might be right for
Hyperphosphatemia Patients on Hemodialysis
Taisho Pharmaceutical Co., Ltd. 101
Large-scale testing (Phase 3)Study completedNCT01191255
What this trial is testing

A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis

Who this might be right for
HyperphosphatemiaKidney Failure
Keryx Biopharmaceuticals 441
Testing effectiveness (Phase 2)Study completedNCT06745518
What this trial is testing

TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders

Who this might be right for
Hyperphosphatemia Patients on Hemodialysis
Taisho Pharmaceutical Co., Ltd. 62
Not applicableStudy completedNCT02684643
What this trial is testing

Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients

Who this might be right for
HyperphosphatemiaEnd-stage Renal Disease
Huashan Hospital 72
Large-scale testing (Phase 3)Looking for participantsNCT07285304
What this trial is testing

A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Who this might be right for
Hyperphosphatemia Patients on Hemodialysis
Taisho Pharmaceutical Co., Ltd. 300
Early research (Phase 1)Study completedNCT02965053
What this trial is testing

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Who this might be right for
Hyperphosphatemia
Chugai Pharmaceutical 26
Testing effectiveness (Phase 2)Study completedNCT00704678
What this trial is testing

Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis

Who this might be right for
Chronic Kidney Disease
Novartis Pharmaceuticals 203
Large-scale testing (Phase 3)Study completedNCT01069692
What this trial is testing

Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients

Who this might be right for
HyperphosphatemiaChronic Kidney Disease
Novartis 115
Large-scale testing (Phase 3)Looking for participantsNCT07548840
What this trial is testing

A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Who this might be right for
Hyperphosphatemia Patients on Hemodialysis
Taisho Pharmaceutical Co., Ltd. 30
Large-scale testing (Phase 3)Study completedNCT01514851
What this trial is testing

Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate

Who this might be right for
Hyperphosphatemia
Bayer 259
Early research (Phase 1)Study completedNCT03305471
What this trial is testing

DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis

Who this might be right for
Hyperphosphatemia
Daiichi Sankyo 40
Not applicableStudy completedNCT05897502
What this trial is testing

Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis

Who this might be right for
End-Stage Kidney DiseaseHyperphosphatemia
Liu, Liu-Yin 43
Large-scale testing (Phase 3)Looking for participantsNCT07285291
What this trial is testing

TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders

Who this might be right for
Hyperphosphatemia Patients on Hemodialysis
Taisho Pharmaceutical Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT03864445
What this trial is testing

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients

Who this might be right for
Hyperphosphatemia
Kyowa Kirin Co., Ltd. 47
Testing effectiveness (Phase 2)Study completedNCT00505037
What this trial is testing

ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Who this might be right for
HyperphosphatemiaChronic Kidney Disease
Astellas Pharma Inc 156
Large-scale testing (Phase 3)Study completedNCT00268957
What this trial is testing

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

Who this might be right for
Kidney DiseasesChronic Renal InsufficiencyEnd-Stage Renal Disease
Genzyme, a Sanofi Company 217
Next Page